Literature DB >> 24735058

Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.

Joni L Strom Williams1, Cheryl P Lynch, Rhonda Winchester, Leslie Thomas, Brad Keith, Leonard E Egede.   

Abstract

OBJECTIVE: Disparities in outcomes for cardiovascular disease (CVD) exist between men and women with type 2 diabetes mellitus (T2DM). We examined gender differences in composite control of cardiovascular risk factors in a sample of adults with T2DM. SUBJECTS AND METHODS: This was a cross-sectional study of 680 people recruited from three primary care settings. Primary outcomes were individual and composite control of CVD risk factors. Control of individual risk outcomes was defined as glycosylated hemoglobin A1c (HbA1c) level of <7%, blood pressure (BP) of <130/80 mm Hg, and low-density lipoprotein (LDL) cholesterol level of <100 mg/dL. Composite control was defined as having all three outcomes under control simultaneously. Linear and logistic regression models were used to assess differences in individual means and individual and composite outcomes control between men and women, while adjusting for relevant covariates.
RESULTS: Men made up 56% of the sample, approximately 67% were non-Hispanic black, and 78% made less than $35,000 annually. Unadjusted mean systolic BP (134 mm Hg vs. 130 mm Hg, P=0.005) and LDL cholesterol (99.7 mg/dL vs. 87.6 mg/dL, P<0.001) levels were significantly higher in women than in men. Adjusted linear regression showed mean diastolic BP (β=3.09; 95% confidence interval 0.56, 5.63) was significantly higher in women. Overall, 12.4% of the sample had composite control, and women had poorer composite control compared with men (5.9% vs. 17.3%). Adjusted logistic models showed that men were significantly more likely to have composite risk factor control (odds ratio 2.90; 95% confidence interval 1.37, 6.13) compared with women.
CONCLUSIONS: In this sample of adults with T2DM, women had significantly lower composite control compared with men, when adjusting for relevant confounders. It is imperative that women are informed about CVD risk factors, educated on how to reduce them, and aggressively treated to avoid adverse outcomes. Additional research involving women is needed to explore and reduce disparities in CVD risk between men and women with T2DM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24735058      PMCID: PMC4074756          DOI: 10.1089/dia.2013.0329

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  31 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

Review 2.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

3.  Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes.

Authors:  Carol J Homko; Linda Zamora; William P Santamore; Abul Kashem; Timothy McConnell; Alfred A Bove
Journal:  Diabetes Educ       Date:  2010-04-01       Impact factor: 2.140

4.  Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-09-16       Impact factor: 17.586

5.  Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD study.

Authors:  Suman Tandon; Frans J T Wackers; Silvio E Inzucchi; Shanti Bansal; Lawrence H Staib; Deborah A Chyun; Janice A Davey; Lawrence H Young
Journal:  Diab Vasc Dis Res       Date:  2012-01-06       Impact factor: 3.291

Review 6.  Managing type 2 diabetes in men.

Authors:  Richard Aguilar
Journal:  J Fam Pract       Date:  2012-06       Impact factor: 0.493

7.  Cardiovascular disease in women.

Authors:  W P Castelli
Journal:  Am J Obstet Gynecol       Date:  1988-06       Impact factor: 8.661

Review 8.  Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease.

Authors:  S M Johnson; C A Karvonen; C L Phelps; S Nader; B M Sanborn
Journal:  J Womens Health (Larchmt)       Date:  2003-06       Impact factor: 2.681

9.  Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.

Authors:  Assiamira Ferrara; Carol M Mangione; Catherine Kim; David G Marrero; David Curb; Mark Stevens; Joseph V Selby
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more
  13 in total

1.  Sex Differences in Outcomes after Stroke in Patients with Diabetes in Ontario, Canada.

Authors:  Mandip S Dhamoon; John W Liang; Limei Zhou; Melissa Stamplecoski; Moira K Kapral; Baiju R Shah
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-09-13       Impact factor: 2.136

Review 2.  Diabetes Mellitus and Heart Failure.

Authors:  Dimitris Tousoulis; Evangelos Oikonomou; Gerasimos Siasos; Christodoulos Stefanadis
Journal:  Eur Cardiol       Date:  2014-07

Review 3.  Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes.

Authors:  Jinsong Geng; Hao Yu; Yiwei Mao; Peng Zhang; Yingyao Chen
Journal:  Pharmacoeconomics       Date:  2015-06       Impact factor: 4.981

4.  Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.

Authors:  LeChauncy D Woodard; Omolola E Adepoju; Amber B Amspoker; Salim S Virani; David J Ramsey; Laura A Petersen; Lindsey A Jones; Lea Kiefer; Praveen Mehta; Aanand D Naik
Journal:  J Gen Intern Med       Date:  2018-04-02       Impact factor: 5.128

5.  Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.

Authors:  Christina M Parrinello; Ina Rastegar; Job G Godino; Michael D Miedema; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2015-04-07       Impact factor: 19.112

6.  Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.

Authors:  Josep Franch-Nadal; Manel Mata-Cases; Irene Vinagre; Flor Patitucci; Eduard Hermosilla; Aina Casellas; Bonaventura Bolivar; Dídac Mauricio
Journal:  Int J Endocrinol       Date:  2014-09-21       Impact factor: 3.257

7.  Patient characteristics associated with measurement of routine diabetes care: an observational study.

Authors:  Arna L Van Doorn-Klomberg; Jozé C C Braspenning; Femke Atsma; Birgit Jansen; Margriet Bouma; René J Wolters; Michel Wensing
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

8.  Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients with Type 2 Diabetes Mellitus and Their Association with Metabolic Syndrome in China.

Authors:  Mei-Fang Yao; Jie He; Xue Sun; Xiao-Li Ji; Yue Ding; Yi-Ming Zhao; Han-Yu Lou; Xiao-Xiao Song; Li-Zhen Shan; Ying-Xiu Kang; Song-Zhao Zhang; Peng-Fei Shan
Journal:  Int J Endocrinol       Date:  2016-11-30       Impact factor: 3.257

9.  Trends in sex differences in the receipt of quality of care indicators among adults with diabetes: United States 2002-2011.

Authors:  Joni S Williams; Kinfe G Bishu; Alessandra St Germain; Leonard E Egede
Journal:  BMC Endocr Disord       Date:  2017-06-06       Impact factor: 2.763

10.  Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka.

Authors:  Thilak Priyantha Weerarathna; Herath Mudiyanselage Meththananda Herath; Gayani Liyanage; Miyuru Kavinda Weerarathna; Vidarsha Senadheera
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-08       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.